Health News Releases

  • Today May 18
September 26, 2018 18:25
WIPO and IFPMA Launch New Online Patent-Search Resource to Help Health Agencies Procure Medicines
WIPO and the research-based pharmaceutical industry today launched a new online tool designed to help procurement agencies better understand the global patent status of medicines. The Patent Inform
September 25, 2018 19:25
Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recom
September 19, 2018 16:00
175 Million Europeans Have Sleep Apnoea, Highlighting Scale of Global Health Crisis
Roughly 175 million Europeans have obstructive sleep apnoea, according to a late-breaking abstract presented by ResMed today at the European Respiratory Society’s annual ERS Congress in Paris. Leading
September 19, 2018 09:00
Aspect Biosystems Announces Liver Tissue Collaboration with JSR
Aspect Biosystems, a privately held biotechnology company focused on commercializing cutting-edge bioprinting technologies, is pleased to announce a new collaboration to develop human liver tissue wit
September 18, 2018 15:55
THE NUVISAN GROUP Continues Its Growth by Adding Parts of the GALDERMA R&D Capabilities from NESTLÉ SKIN HEALTH
On August 31st the NUVISAN GROUP, one of Europe´s leading CRO´s focused on early stage drug development for the life science industry, signed an agreement with NESTLÉ SKIN HEALTH/ GALDERMA to take ove
September 17, 2018 22:05
MEDTEX: Foresee the Next Wave of Healthcare Revolution
Taiwan, with high quality medical service and world’s top IT industry, has becoming one of the leaders in global healthcare technology and provider. On November 29 - 30, MEDTEX will focus on 3 key tre
September 17, 2018 18:15
Large European real-world study reports effects of Spiolto® Respimat® for people living with COPD in daily clinical practice[1]
For media excluding the United States of America, Canada and the United Kingdom Boehringer Ingelheim announced results from the OTIVACTO study, an observational European real-world study of 7,443 C
September 17, 2018 10:15
Clinical trial data for nintedanib in patients with advanced IPF published
Results from the INSTAGE® trial have been presented at the 2018 European Respiratory Society (ERS) conference in Paris and published in the New England Journal of Medicine.[1] The trial reports clinic
September 17, 2018 10:05
New study results provide evidence that Ofev® (nintedanib) slows progression of IPF beyond four years with consistent safety
Results from INPULSIS®-ON, published today in Lancet Respiratory Medicine, provide insights into the long-term safety, efficacy and tolerability of Ofev® (nintedanib) in patients with idiopathic pulmo
September 14, 2018 16:00
ResMed Introduces Its First Minimal-contact Full Face CPAP Mask, AirFit F30
ResMed (NYSE: RMD) (ASX: RMD) today introduced its first minimal-contact full face CPAP mask, AirFit F30, the latest addition to its AirFit mask portfolio, which helps users reduce facial marks, wear
September 14, 2018 15:00
Acelity Enters Agreement to Transition Systagenix Manufacturing Facility to Scapa Healthcare
Today, Acelity announced an agreement to sell its advanced wound dressings manufacturing facility located in Gargrave, England, to Scapa Healthcare. In conjunction with the transfer of the facility up
September 13, 2018 18:25
Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
Boehringer Ingelheim today announced that it has acquired all shares of ViraTherapeutics, a biopharmaceutical company specializing in the development of oncolytic viral therapies. ViraTherapeutics dev
September 13, 2018 17:30
OptraSCAN® Receives CE Mark Approval for In-Vitro Diagnostics Use
OptraSCAN®, the leading end-to-end digital pathology solution provider, today announced that their whole-slide scanners have received CE Mark approval for European Standards applicable to “In-Vitro Di
September 13, 2018 10:10
OTEZLA® (Apremilast) Showed Meaningful Improvements in Clinical and Quality-of-Life Measures of Psoriasis Beyond Those Captured by Assessing Skin Alone
Celgene Corporation (NASDAQ:CELG) today announced the results of two post hoc sub-analyses of clinical trials for OTEZLA® (apremilast) at the 27th European Academy of Dermatology and Venereology (EADV
September 10, 2018 22:05
dClinic(DHC) Phase 1 - Over 50% SOLD in first 10 days
“Current Blockchains are not dedicated Healthcare blockchains. They are not purpose built to handle fractal clinical data nor do they pass the scrutiny of worldwide security protocols for clinical dat
September 07, 2018 09:45
Swiss Advanced Vision Launches Harmonis - The First Customizable EDOF IOL for Cataract Surgery
Swiss Advanced Vision (SAV-IOL) has announced the launch of Harmonis, a customizable intraocular lens (IOL) with advanced extended depth of focus (EDOF) optical technology for cataract surgery. For th
September 06, 2018 14:40
JAMA Publishes Greatly Anticipated Phase III Study Using 22nd Century’s SPECTRUM® Very Low Nicotine Content Cigarettes
22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company focused on tobacco harm reduction and Very Low Nicotine tobacco, announced today that the Journal of the American Medical
September 06, 2018 10:50
New Study Compares Two Methods of Guiding Goal-Directed Fluid Therapy, Noninvasive Masimo PVi® and Invasive Esophageal Doppler
Masimo (NASDAQ: MASI) announced today the findings of a study recently published in BMC Anesthesiology in which researchers at University Hospital Linköping, Sweden, compared the performance of goal-d
September 05, 2018 10:15
Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
Boehringer Ingelheim and Tsinghua University in Beijing announce a collaboration aiming to research and develop immunological therapies for infectious diseases. Scientists will work in the Boehringer
September 03, 2018 13:45
GNT Pharma's Ropesalazine Effective in Treating Dog Dementia
GNT Pharma said Ropesalazine, a drug candidate for Alzheimer’s disease (AD), has shown an outstanding beneficial efficacy in a pilot clinical trial conducted for dogs with cognitive dysfunction syndro
September 03, 2018 11:40
ResMed Files Patent Infringement Action against Fisher & Paykel
ResMed (NYSE: RMD) (ASX: RMD), the world’s leading tech-driven medical device company and innovator in sleep apnea and respiratory care, today filed a petition with the United States International Tra
August 31, 2018 11:55
Nebula Genomics Raises $4.3M Seed Financing From Leading Tech and Biotech VCs
Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 leading venture capital firms. The funds will support the company’s mission to usher in th
August 31, 2018 10:50
Ferring and Celmatix Launch Ambitious Genomics Collaboration to Advance Care in Reproductive Medicine and Women’s Health
Ferring Pharmaceuticals and Celmatix today announced an ambitious genomics collaboration aimed at uncovering new insights into ovarian biology and accelerating the development of personalized interven
August 28, 2018 14:00
ResMed’s Astral Life Support Ventilator Now Has AutoEPAP in U.S.
ResMed (NYSE: RMD) (ASX: RMD), a global leader in cloud-connected respiratory care devices, today announced key upgrades to its Astral life support ventilators, including Optional AutoEPAP in iVAPS fo
August 28, 2018 11:25
New Study Evaluates the Ability of Masimo ORi™ to Reflect Oxygenation During Moderate Hyperoxia
Masimo (NASDAQ: MASI) announced today the findings of a study recently published in Anesthesia & Analgesia in which researchers at the University of Groningen, the Netherlands, and Ghent University, B
25 per page50 per page75 per page100 per page